Clinically Approved Nanoparticle Imaging Agents

Avnesh S. Thakor, Jesse V. Jokerst, Pejman Ghanouni, Jos L. Campbell, Erik Mittra, Sanjiv S. Gambhir

Research output: Contribution to journalArticle

60 Scopus citations

Abstract

Nanoparticles are a new class of imaging agent used for both anatomic and molecular imaging. Nanoparticle-based imaging exploits the signal intensity, stability, and biodistribution behavior of submicron-diameter molecular imaging agents. This review focuses on nanoparticles used in human medical imaging, with an emphasis on radionuclide imaging and MRI. Newer nanoparticle platforms are also discussed in relation to theranostic and multimodal uses.

Original languageEnglish (US)
Pages (from-to)1833-1837
Number of pages5
JournalJournal of Nuclear Medicine
Volume57
Issue number12
DOIs
StatePublished - Dec 1 2016

Keywords

  • Imaging and diagnostics
  • Medical imaging
  • Molecular imaging
  • Nanoparticle
  • Nanoparticles

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging

Fingerprint Dive into the research topics of 'Clinically Approved Nanoparticle Imaging Agents'. Together they form a unique fingerprint.

  • Cite this

    Thakor, A. S., Jokerst, J. V., Ghanouni, P., Campbell, J. L., Mittra, E., & Gambhir, S. S. (2016). Clinically Approved Nanoparticle Imaging Agents. Journal of Nuclear Medicine, 57(12), 1833-1837. https://doi.org/10.2967/jnumed.116.181362